Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1226
Brown-Forman Class B
BF.B
$14.1B
| $20.9M | ﹤0.01% |
799,033
+475,102
| +147% | +$12.8M |
2013 Q2
53 quarters
|
|
1227
Corebridge Financial
CRBG
$15.9B
| $20.9M | ﹤0.01% |
630,307
+358,360
| +132% | +$11.7M |
2022 Q3
16 quarters
|
|
1228
Royalty Pharma
RPRX
$30.9B
| $20.8M | ﹤0.01% |
356,020
-266,413
| -43% | -$15.7M |
2022 Q1
18 quarters
|
|
1229
Upstart Holdings
UPST
$1.93B
| $20.7M | ﹤0.01% |
901,244
-227,731
| -20% | -$6.52M |
2022 Q1
18 quarters
|
|
1230
Wintrust Financial
WTFC
$10.5B
| $20.7M | ﹤0.01% |
145,926
+121,428
| +496% | +$18.9M |
2013 Q2
53 quarters
|
|
1231
MP Materials
MP
$6.91B
| $20.7M | ﹤0.01% |
437,510
+233,934
| +115% | +$11.9M |
2022 Q1
18 quarters
|
|
1232
Tarsus Pharmaceuticals
TARS
$3.96B
| $20.6M | ﹤0.01% |
261,801
+225,143
| +614% | +$15.6M |
2022 Q1
18 quarters
|
|
1233
Texas Roadhouse
TXRH
$12.2B
| $20.6M | ﹤0.01% |
131,629
+75,656
| +135% | +$14.4M |
2013 Q2
53 quarters
|
|
1234
Texas Pacific Land
TPL
$20.1B
| $20.6M | ﹤0.01% |
63,071
-15,811
| -20% | -$5.97M |
2022 Q1
18 quarters
|
|
1235
MGIC Investment
MTG
$5.52B
| $20.5M | ﹤0.01% |
792,970
-97,033
| -11% | -$2.9M |
2013 Q2
53 quarters
|
|
1236
Rocket Companies
RKT
$38.9B
| $20.5M | ﹤0.01% |
1,778,961
+1,180,777
| +197% | +$16.2M |
2022 Q1
18 quarters
|
|
1237
CALL
Applovin
APP
$136B
| $20.5M | ﹤0.01% |
70,500
+61,700
| +701% | +$22.7M |
2024 Q4
7 quarters
|
|
1238
Crocs
CROX
$7.49B
| $20.5M | ﹤0.01% |
174,415
+2,831
| +2% | +$357K |
2013 Q2
53 quarters
|
|
1239
Essential Utilities
WTRG
$13B
| $20.4M | ﹤0.01% |
521,301
+324,717
| +165% | +$13M |
2022 Q1
18 quarters
|
|
1240
Allison Transmission
ALSN
$10.4B
| $20.4M | ﹤0.01% |
180,309
+97,400
| +117% | +$11.8M |
2013 Q2
53 quarters
|
|
1241
First Citizens BancShares
FCNCA
$25.7B
| $20.4M | ﹤0.01% |
9,898
+3,313
| +50% | +$7.13M |
2016 Q1
42 quarters
|
|
1242
Aptiv
APTV
$7.84B
| $20.4M | ﹤0.01% |
473,053
-28,044
| -6% | -$1.42M |
2013 Q4
51 quarters
|
|
1243
SM Energy
SM
$7.69B
| $20.3M | ﹤0.01% |
602,252
+495,768
| +466% | +$16.6M |
2013 Q2
53 quarters
|
|
1244
BioMarin Pharmaceuticals
BMRN
$11.1B
| $20.3M | ﹤0.01% |
338,897
+135,533
| +67% | +$8.54M |
2013 Q2
53 quarters
|
|
1245
monday.com
MNDY
$3.3B
| $20.3M | ﹤0.01% |
258,509
+151,472
| +142% | +$13.1M |
2022 Q1
18 quarters
|
|
1246
Alphabet Inc Depositary Shares Series B Preferred Stock
GOOGN
| $20.3M | ﹤0.01% |
417,730
+85,445
| +26% | +$4.19M |
2026 Q2
1 quarter
|
|
1247
Credicorp
BAP
$29.3B
| $20.2M | ﹤0.01% |
53,252
-10,699
| -17% | -$4.11M |
2013 Q4
51 quarters
|
|
1248
Travere Therapeutics
TVTX
$4.86B
| $20.2M | ﹤0.01% |
343,543
+323,783
| +1,639% | +$19.8M |
2022 Q1
18 quarters
|
|
1249
Centrus Energy
LEU
$2.14B
| $20.2M | ﹤0.01% |
144,616
+90,815
| +169% | +$15.3M |
2021 Q1
22 quarters
|
|
1250
CubeSmart
CUBE
$10B
| $20.1M | ﹤0.01% |
536,054
+90,203
| +20% | +$3.65M |
2013 Q2
53 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.